Literature DB >> 17912564

Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease.

Shigeyuki Sakamoto1, Yoshihiro Kiura, Fumiyuki Yamasaki, Masaaki Shibukawa, Shinji Ohba, Prabin Shrestha, Kazuhiko Sugiyama, Kaoru Kurisu.   

Abstract

Vascular endothelial growth factor (VEGF) has been found to be involved in vasculogenesis in different intracranial lesions. We investigated meningeal cellularity and VEGF expression in dura mater of patients with and without moyamoya disease. Nine dural specimens from nine cerebral hemispheres of seven patients with moyamoya disease and four control dural specimens from four non-moyamoya patients were collected during surgery and investigated. Dural specimens were immunohistochemically stained with VEGF antibody, and then meningeal cellularity and VEGF expression in dural tissue were analyzed. The mean+/-standard error (SE) of total number of meningeal cells (meningeal cellularity) in dural tissue was 21.5+/-3.0 in the moyamoya disease patients, whereas it was 2.7+/-0.7 in control patients. The mean+/-SE of VEGF expression was 51.1+/-4.9% in the moyamoya disease patients, whereas it was 13.8+/-5.9% in control patients. The meningeal cellularity and VEGF expression were statistically significantly higher in the moyamoya group in comparison to control group (p<0.0001). Meningeal cellularity and VEGF expression are significantly increased in dura mater of the patients with moyamoya disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17912564     DOI: 10.1007/s10143-007-0102-8

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  18 in total

Review 1.  Update on therapeutic neovascularization.

Authors:  Yihai Cao; An Hong; Henny Schulten; Mark J Post
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

2.  Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study.

Authors:  M Hoshimaru; J A Takahashi; H Kikuchi; I Nagata; M Hatanaka
Journal:  J Neurosurg       Date:  1991-08       Impact factor: 5.115

3.  Cranial burr hole for revascularization in moyamoya disease.

Authors:  M Endo; N Kawano; Y Miyaska; K Yada
Journal:  J Neurosurg       Date:  1989-08       Impact factor: 5.115

4.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

5.  Use of a split dura for revascularization of ischemic hemispheres in moyamoya disease.

Authors:  S Kashiwagi; S Kato; S Yasuhara; Y Wakuta; T Yamashita; H Ito
Journal:  J Neurosurg       Date:  1996-09       Impact factor: 5.115

6.  Dural inversion procedure for moyamoya disease. Technical note.

Authors:  R C Dauser; G F Tuite; C W McCluggage
Journal:  J Neurosurg       Date:  1997-04       Impact factor: 5.115

7.  Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease.

Authors:  Yoshinori Takekawa; Takehiko Umezawa; Yuichi Ueno; Tatsuo Sawada; Makio Kobayashi
Journal:  Neuropathology       Date:  2004-09       Impact factor: 1.906

8.  Childhood moyamoya disease before and after encephalo-duro-arterio-synangiosis: an angiographic study.

Authors:  I Yamada; Y Matsushima; S Suzuki
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

9.  Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.

Authors:  H Hoshi; T Ohnishi; S Jinnouchi; S Futami; S Nagamachi; T Kodama; K Watanabe; T Ueda; S Wakisaka
Journal:  J Nucl Med       Date:  1994-01       Impact factor: 10.057

10.  Cerebral hemodynamic change in the child and the adult with moyamoya disease.

Authors:  Y Kuwabara; Y Ichiya; M Otsuka; T Tahara; R Gunasekera; K Hasuo; K Masuda; T Matsushima; M Fukui
Journal:  Stroke       Date:  1990-02       Impact factor: 7.914

View more
  15 in total

Review 1.  Pediatric de novo cerebral AVM: report of two cases and review of literature.

Authors:  Jared J Y Yeo; Sharon Y Y Low; Wan Tew Seow; David C Y Low
Journal:  Childs Nerv Syst       Date:  2014-12-24       Impact factor: 1.475

Review 2.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

3.  Cephalometric Features of Moyamoya Disease: A case control study.

Authors:  Adnan I Qureshi; Waqas I Gilani; Sarwat I Gilani; Malik M Adil
Journal:  J Vasc Interv Neurol       Date:  2014-11

4.  Moyamoya syndrome in sickle cell anaemia: a cause of recurrent stroke.

Authors:  Deanne Soares; Richard Bullock; Susanna Ali
Journal:  BMJ Case Rep       Date:  2014-09-01

5.  Significance of cyclooxygenase-2 elevation in middle cerebral artery for patients with hemorrhagic moyamoya disease.

Authors:  Jian-Jian Zhang; Zhong-Wei Xiong; Sheng Wang; Shou-Jia Sun; Hao Wang; Xiao-Lin Wu; Long Wang; Hua-Qiu Zhang; Chao You; Yu Wang; Jin-Cao Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

Review 6.  Pathological Circulating Factors in Moyamoya Disease.

Authors:  Yao-Ching Fang; Ling-Fei Wei; Chaur-Jong Hu; Yong-Kwang Tu
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

7.  The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; Kyu Young Chae; Seung-Hun Oh; In Bo Han; Hyun Sook Kim; Won-Chan Kim; Ok-Joon Kim; Tae Gon Kim; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

Review 8.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

Review 9.  Single Nucleotide Polymorphism in Patients with Moyamoya Disease.

Authors:  Young Seok Park
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

10.  Is there a role for treating inflammation in moyamoya disease?: a review of histopathology, genetics, and signaling cascades.

Authors:  Adam M H Young; Surya K Karri; Christopher S Ogilvy; Ninghui Zhao
Journal:  Front Neurol       Date:  2013-08-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.